Using Biomarkers to Plan Adjuvant Therapy in Breast Cancer

Lisa Carey, MD, will discuss the anatomic and genomic variables that impact on (neo)adjuvant decision-making in breast cancer and the current treatment algorithms that allow rational escalation and de-escalation of systemic therapy.

Course summary
Available credit: 
  • 1.00 Participation
Course opens: 
08/10/2021
Course expires: 
12/31/2021
Rating: 
0

Available Credit

  • 1.00 Participation
Please login or register to take this course.